MICHAEL EGLAND: Open Payments
NPI 1972192227 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 20 payments from 5 companies in 2025. Trend: 2023 $761 · 2024 $688 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $205 |
| Ipsen Biopharmaceuticals, Inc | 1 | $62 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
Products named: RINVOQ, IQIRVO, SKYRIZI, MAVYRET, REZDIFFRA, CREON, ZENPEP, ACCRUFER.
Industry payments across ID — which companies pay providers there.
